Plasma Levels of Interleukin 1β and Interleukin 6 in Mental Disorders
It was concluded from alterations of interleukins in CSF and plasma that patients with schizophrenia and major depression exhibit an acute stimulation of the immune system [1, 2, 3, 4]. In this context an underlying autoimmune process was assumed in the pathology of schizophrenia and major depression. Especially schizophrenia with its relapsing and chronic forms reminds of the course of autoimmune diseases like chronic rheumatic illness [5, 6].
KeywordsMajor Depression Schizophrenic Patient Paranoid Schizophrenia BioI Psychiatry Phrenic Patient
Unable to display preview. Download preview PDF.
- Ganguli R, McAllister CG, Rabin BS, Solomon W, Brar JS, Rehn I (1991) Alterations in interleukins and in lymphocyte subsets in a subgroup of schizophrenia. Biol Psychiatry 29:109 AGoogle Scholar
- Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH (1993) Elevated CSF levels of interleukin-2 in neuroleptic free schizophrenic patients. Am J Psychiatry ISO: 1408 – 1410Google Scholar
- Maes M, Stevens WJ, Declerck LS, Bridts CH, Peeters D, Schotte G, Cosyns P (1993) Significantly increased expression of T-cell activation markers (Interleu-kin-2 and HAL-DR) in depression. Further evidence for an inflammatory process during that illness. Progr Neuropsychopharmacol Biol Psychiatry H: 241 – 255Google Scholar
- Schott K, Batra A, Klein R, Battels M, Koch W, Berg PA (1992) Antibodies against serotonin and gangliosides in schizophrenia and major depressive disorder. Eur Psychiatry 7: 209 – 212Google Scholar
- Brauchitsch H (1972) Antinuclear factor in psychiatric disorders. Am J Psychiatry 128: 1552 – 1554Google Scholar